No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
LLY240705P700000
- 0.49
- 0.000.00%
15min DelayTrading Jul 2 11:24 ET
0.00High0.00Low
0.00Open0.49Pre Close0 Volume6 Open Interest700.00Strike Price0.00Turnover141.79%IV23.40%PremiumJul 5, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.49Extrinsic Value100Contract SizeAmericanOptions Type-0.0124Delta0.0003Gamma1863.78Leverage Ratio-0.4267Theta-0.0008Rho-23.08Eff Leverage0.0248Vega
Intraday
- 5D
- Daily
News
Biden and Sanders teamed up to pressure Novo Nordisk and Eli Lilly to lower the price of weight loss drugs.
① Biden pointed out that the prices of pharmaceutical products from Novo-Nordisk and Eli Lilly and Co are "unreasonably high" and far exceed those of other countries, which is unacceptable. ② If these pharmaceutical companies refuse to significantly reduce prescription drug prices in the United States and end their greedy behavior, we will do "everything we can to help them stop this behavior."
Eli Lilly and Co has finally received approval from the USA's FDA, and there will be a two-horse race in the field of Alzheimer's disease.
Eli Lilly and Co executives wrote that Kisunla has shown a very meaningful effect, and patients urgently need this effective treatment plan.
Top 3 Health Care Stocks That May Crash This Quarter
As of July 3, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.The RSI is a momentum indicator
Jefferies Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Raises Target Price to $1,041
Jefferies analyst Akash Tewari maintains $Eli Lilly and Co(LLY.US)$ with a buy rating, and adjusts the target price from $1,015 to $1,041.According to TipRanks data, the analyst has a success rate of
Evercore Maintains Eli Lilly and Co(LLY.US) With Hold Rating
Evercore analyst Umer Raffat maintains $Eli Lilly and Co(LLY.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 44.4% and a total average return of -8.8% over the pa
A Quick Look at Today's Ratings for Eli Lilly and Co(LLY.US), With a Forecast Between $1,001 to $1,041
On Jul 03, major Wall Street analysts update their ratings for $Eli Lilly and Co(LLY.US)$, with price targets ranging from $1,001 to $1,041.Morgan Stanley analyst Terence Flynn maintains with a buy ra